SSKN (STOCKS)
Strata Skin Sciences, Inc. Common Stock
$0.359300
-0.840700 (-70.06%)
Prev close: $1.200000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Medical Specialties
- CEO
- Dolev Rafaeli
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $2.25M
- Employees
- 106
- P/E (TTM)
- -0.15
- P/B (TTM)
- 1.56
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
3
Strong Buy
4
Buy
1
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Sep 2025 (Q3)
|
$-0.36 | $-0.39 | +0.0337 | +8.56% |
|
Jun 2025 (Q2)
|
$-0.60 | $-0.29 | -0.3068 | -104.64% |
|
Mar 2025 (Q1)
|
$-0.58 | $-0.53 | -0.0537 | -10.20% |
|
Dec 2024 (Q4)
|
$-1.13 | $-0.30 | -0.8255 | -271.10% |
Financial Statements
| Revenues | $30.98M |
| Benefits Costs and Expenses | $50.93M |
| Cost Of Revenue | $13.09M |
| Costs And Expenses | $27.36M |
| Gross Profit | $17.89M |
| Nonoperating Income/Loss | -$1.57M |
| Operating Expenses | $27.36M |
| Depreciation and Amortization | $4.53M |
| Research and Development | $554.00K |
| Other Operating Expenses | $23.36M |
| Operating Income/Loss | -$9.47M |
| Income/Loss From Continuing Operations After Tax | -$10.87M |
| Income/Loss From Continuing Operations Before Tax | -$11.86M |
| Income Tax Expense/Benefit | -$170.00K |
| Net Income/Loss | -$10.87M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$10.87M |
| Net Income/Loss Available To Common Stockholders, Basic | -$10.87M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$2.63 |
| Diluted Earnings Per Share | -$2.63 |
| Basic Average Shares | 4,397,899 |
| Diluted Average Shares | 4,397,899 |
| Assets | $30.72M |
| Current Assets | $14.27M |
| Inventory | $3.06M |
| Other Current Assets | $11.21M |
| Noncurrent Assets | $16.45M |
| Fixed Assets | $9.56M |
| Intangible Assets | $4.22M |
| Other Non-current Assets | $2.67M |
| Liabilities | $29.40M |
| Current Liabilities | $15.03M |
| Accounts Payable | $2.96M |
| Wages | $1.96M |
| Other Current Liabilities | $10.11M |
| Noncurrent Liabilities | $14.37M |
| Long-term Debt | $15.31M |
| Equity | $1.31M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $1.31M |
| Liabilities And Equity | $30.72M |
| Net Cash Flow From Operating Activities | -$1.85M |
| Net Cash Flow From Operating Activities, Continuing | -$1.85M |
| Net Cash Flow From Investing Activities | -$1.66M |
| Net Cash Flow From Investing Activities, Continuing | -$1.66M |
| Net Cash Flow From Financing Activities | $2.19M |
| Net Cash Flow From Financing Activities, Continuing | $2.19M |
| Net Cash Flow | -$1.32M |
| Net Cash Flow, Continuing | -$1.32M |
| Comprehensive Income/Loss | -$10.87M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$10.87M |
| Other Comprehensive Income/Loss | $0.00 |